ArticleGastro hep advances2025
Sex and Race Disparities in Liver Listings and Transplants in the United States.
Article in Gastro hep advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Alcohol-associated liver disease (ALD) and metabolic dysfunction-associated steatohepatitis (MASH) are becoming leading indications for liver transplant (LT) in the United States. Data on trends based on sex and race are limited. Methods: A cohort of LT listings in adults (2011-2023) for common indications of ALD, MASH, and hepatitis C virus was stratified to hepatocellular carcinoma (HCC) and non-HCC indications. Change in proportion for each etiology in 2023 vs 2011 was derived. Results: Of 21,087 HCC listings, MASH dominated in males and females, but ALD dominated in black males and in black and Hispanic females. Of 12,087 HCC LT, MASH dominated in both sexes and races, except ALD dominated in black males. Of 80,433 non-HCC listings, ALD dominated in both sexes and races, except MASH dominated in black and Hispanic males. Of 46,289 non-HCC LT, ALD dominated in both sexes and all races. Conclusion: Our study findings call for public policies to address the rising burden from ALD and MASH and sex/ethnic disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.